Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tooth-Saving showdown: which pulp capping material wins?

NCT ID NCT07562555

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two materials, ProRoot MTA and Biofactor MTA, for direct pulp capping—a procedure to save a tooth's nerve after exposure. Eighty permanent teeth were treated, and patients reported pain levels for 48 hours. Success was checked at 6 and 12 months by looking for symptoms like pain or swelling and X-ray signs of infection. The goal was to see if Biofactor MTA works as well as the standard ProRoot MTA.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ProRoot MTA and Biofactor MTA (calcium silicate-based materials used in dental procedures)
What this could lead to
If successful, this could show that Biofactor MTA is as effective as ProRoot MTA for preserving tooth vitality, offering a reliable alternative for dental pulp therapy.
What could go wrong
This is a small, completed study with 80 participants, so results may not apply to all patients. Long-term success beyond 12 months is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Jan 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged between 13 and 65 years * Patients with adequate patient-clinician communication * Patients who agree to attend periodic follow-up visits throughout the study * Patients who provide written informed consent to participate in the study * Systemically healthy patients * Teeth with no previous endodontic treatment * Teeth showing a positive response to cold and electric pulp test * Permanent teeth * Posterior teeth * Teeth that can be restored with direct composite restoration * Teeth with pulp exposure (pulpal perforation) * Presence of bleeding from the exposed pulp that can be controlled within 5-10 minutes Exclusion Criteria: * Patients who refuse to participate in the study * Medically compromised patients (e.g., patients with systemic diseases, immunological disorders, or those using medications) * Patients with known allergies to materials used during vital pulp therapy * Pregnant patients * Non-vital teeth * Presence of advanced periodontal disease (probing depth \> 3 mm) * Teeth with previous endodontic treatment * Teeth with insufficient remaining tooth structure that cannot be restored with restorative materials * Teeth where adequate isolation cannot be achieved * Teeth requiring post core restoration * Patients in whom periapical radiographs cannot be obtained * Patients unable to attend follow-up visits * Cases in which bleeding from the exposed pulp cannot be controlled within 5-10 minutes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Vital pulp exposure in permanent teeth are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ege University Faculty of Dentistry

    Izmir, 35100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.